Page last updated: 2024-08-21

thiazoles and trinitrobenzenesulfonic acid

thiazoles has been researched along with trinitrobenzenesulfonic acid in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gilbertsen, R; Guglietta, A; Kraus, ER; Lesch, CA; Sanchez, B1
Auwerx, J; Chambon, P; Colombel, JF; Derijard, B; Desreumaux, P; Desvergne, B; Dubuquoy, L; Englaro, W; Leibowitz, MD; Nutten, S; Peuchmaur, M; Schoonjans, K; Wahli, W1
Khan, I; Oriowo, MA1
Gandhi, R; Goettel, JA; Griffith, AE; Kenison, JE; Murugaiyan, G; Patel, B; Quintana, FJ; Sambanthamoorthy, S; Shouval, DS; Snapper, SB; Weiner, HL; Yeste, A1

Other Studies

4 other study(ies) available for thiazoles and trinitrobenzenesulfonic acid

ArticleYear
Lack of beneficial effect of COX-2 inhibitors in an experimental model of colitis.
    Methods and findings in experimental and clinical pharmacology, 1999, Volume: 21, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Isoenzymes; Male; Nitrobenzenes; Peroxidase; Peroxidases; Phenols; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Thiazoles; Trinitrobenzenesulfonic Acid

1999
Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.
    The Journal of experimental medicine, 2001, Apr-02, Volume: 193, Issue:7

    Topics: Animals; Colitis; Dimerization; Drug Synergism; Mice; Mice, Mutant Strains; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Trinitrobenzenesulfonic Acid

2001
Mechanism underlying the reversal of contractility dysfunction in experimental colitis by cyclooxygenase-2 inhibition.
    Inflammopharmacology, 2006, Volume: 14, Issue:1-2

    Topics: Animals; Blotting, Western; Carbachol; Colitis; Colon; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Gastrointestinal Motility; Isometric Contraction; Male; Malondialdehyde; Meloxicam; Muscle, Smooth; p38 Mitogen-Activated Protein Kinases; Peroxidase; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thiazines; Thiazoles; Trinitrobenzenesulfonic Acid

2006
AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice.
    Cell reports, 2016, 10-25, Volume: 17, Issue:5

    Topics: Animals; Colitis; Disease Models, Animal; Forkhead Transcription Factors; Humans; Mice; Receptors, Aryl Hydrocarbon; T-Lymphocytes, Regulatory; Thiazoles; Transforming Growth Factor beta1; Trinitrobenzenesulfonic Acid

2016